The Indoleamine 2,3-Dioxygenase Pathway Controls Complement-Dependent Enhancement of Chemo-Radiation Therapy Against Murine Glioblastoma

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-21

Related search